NanoSight Acquired by Malvern Instruments
Malvern Instruments (Malvern, UK) has acquired NanoSight (Amesbury, UK), a nanoparticle characterization company. The acquisition was completed on 27 September 2013.
Image caption: Malvern Instruments senior management meets the NanoSight team
Malvern Instruments (Malvern, UK) has acquired NanoSight (Amesbury, UK), a nanoparticle characterization company. The acquisition was completed on 27 September 2013.
NanoSight employs approximately 50 people worldwide. The company will continue to operate from its current facilities in Amesbury under its existing management team. NanoSight instruments and aftersales support will now be accessible to a wider geographical area.
Paul Walker, Managing Director of Malvern Instruments, said: “NanoSight is a real entrepreneurial success story and I am delighted to be welcoming the NanoSight team to Malvern. NanoSight has grown every year since it was established in 2002 and has ambitious plans for the future. We will be providing the investment and support needed to continue this drive forward and are absolutely committed to developing the NanoSight brand within the Malvern portfolio.”
Jeremy Warren, CEO of NanoSight, said, “We have always seen Malvern as the clear leader in our sector, and the exemplar of what we wish to become. The plans we have are ambitious and exciting, and the support and reach of the Malvern organization will allow us to grow more rapidly than we could alone. I am sure that this change will bring opportunity to both our business and our colleagues. Malvern is our natural home.”
For more information please visit
www.nanosight.com
or
www.malvern.com
Interpreting Metabolites and Biosynthetic Pathways of Musk with GC–MS
May 22nd 2025Gas chromatography–mass spectrometry (GC–MS) was used to detect the chemical components of natural musk, harvested from forest musk deer at multiple stages of maturity. This research combines metabolomic profiling with biosynthetic pathway analysis to identify potential precursors and enzymes involved in musk biosynthesis.
HPLC 2025 Preview: HPLC 2025 Hits Bruges
May 22nd 2025The 54th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC 2025) will be held from Sunday through Thursday, June 15–19 2025, in Bruges, Belgium. LCGC International spoke to the Scientific Committee to find out what’s in store.
Quantifying Isavuconazole in Dried Blood Spots Using HPLC
May 21st 2025Isavuconazole, an antimycotic agent used to treat fungal infections, can typically be found during dried blood spot sampling. However, there are obstacles that keep it from being an ideal approach for properly determining the drug’s presence.
